Mandaviya calls for collaboration to eliminate vector borne diseases

Sanofi Global Health launches nonprofit Impact brand for 30 medicines in low-income countries

Medicines, including insulin, to be available in 40 lower-income countries

HIL to commercialise VCRC Bti bio-larvicide technology for mosquito vector control programs

HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project

Merck KGaA to expand its membrane and filtration manufacturing facility in Ireland

The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland

Dr Mansukh Mandaviya promises to introduce `Made in India’ TB infection skin test kit

This cost-effective tool will be of immense benefit to other high burden countries as well.

CCMB develops India’s first mRNA vaccine technology

The mRNA vaccine candidate is fully indigenous and devoid of any technology contributions from elsewhere

WHO selects Biological E for mRNA tech transfer

Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer

Govt signs agreement with Sapigen Biologix to develop two vaccines

Under the agreement, Technology Development Board and Bharat Biotech have pledged the support of Rs.200 crore each to create a continuous corpus of Rs.400 crores for the project

Govt to deploy Truenat platform for TB screening across India

It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour

Botanical Solution Inc. raises $6.1 million in Series A

The company develops sustainable botanical materials for agricultural and pharmaceutical applications